IBM and the Ontario Centres of Excellence launched a startup hub in Toronto this week, enrolling e-health player Analytics 4 Life as its first participant.

Intrexon has done deals with two of the portfolio companies from a fund dedicated to promoting the use of the synthetic biology player's tech: Genten…

Philips is teaming up with Sydney’s Macquarie University and Emory Healthcare in Atlanta on Australia’s first remote intensive care unit monitoring program.

Israeli biotech BioLineRx was up about 25% in early trading on news that it has done a second in-licensing deal for a nonalcoholic steatohepatitis (NASH)…

BioMérieux spinoff Biotheranostics has been looking to chart more progress for its cancer tests since leaving its French parent earlier this year. Now it’s…

Diagnostics player T2 Biosystems nabbed $40 million in a private placement from Canon U.S.A, which it will use to boost its business and drive the development…

Spirox is touting results from a study of its Latera absorbable nasal implant, a device designed to fight nasal valve collapse and obstruction.

BioNTech lands a $310 million Genentech deal, a DNA repair startup raises $33 million and Alnylam commits to Britain. And more.

Teva has posted positive Phase III data for its involuntary twitch candidate deutetrabenazine as its gears up for a 2016 FDA filing--putting it a few months…